Human papillomavirus and molecular considerations for cancer risk (Q37315925)

19 August 2017

1 reference

title

Human papillomavirus and molecular considerations for cancer risk (English)

1 reference

19 August 2017

Martin A Whiteside

1

1 reference

19 August 2017

Erin M Siegel

series ordinal

2

1 reference

19 August 2017

Elizabeth R Unger

series ordinal

3

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

19 August 2017

1 reference

19 August 2017

113

1 reference

19 August 2017

2981-2994

1 reference

19 August 2017

10 Suppl

1 reference

Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers

19 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

Molecular markers for early detection of cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

Biomarkers in cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

Human papillomavirus (HPV) types 101 and 103 isolated from cervicovaginal cells lack an E6 open reading frame (ORF) and are related to gamma-papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Cervical cancer: prevention, diagnosis, and therapeutics

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Human papillomavirus life cycle: active and latent phases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Papillomaviruses and cancer: from basic studies to clinical application

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Chapter 5: Viral and host factors in human papillomavirus persistence and progression.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Interaction of the HPV E7 proteins with the pCAF acetyltransferase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Viral oncoproteins target the DNA methyltransferases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Cellular binding partners of the human papillomavirus E6 protein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Biological activities and molecular targets of the human papillomavirus E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Transforming growth factor beta suppresses human telomerase reverse transcriptase (hTERT) by Smad3 interactions with c-Myc and the hTERT gene

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Regulation of telomerase and telomeres: human tumor viruses take control

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The death-associated protein kinases: structure, function, and beyond

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Self-eating and self-killing: crosstalk between autophagy and apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Human scribble, a novel tumor suppressor identified as a target of high-risk HPV E6 for ubiquitin-mediated degradation, interacts with adenomatous polyposis coli

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The APC-hDLG complex negatively regulates cell cycle progression from the G0/G1 to S phase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

PDZ domain proteins: scaffolds for signaling complexes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Wnt signaling: is the party in the nucleus?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

FGF Signaling Regulates Mesoderm Cell Fate Specification and Morphogenetic Movement at the Primitive Streak

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

E-cadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus-associated (pre)neoplastic lesions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Genome wide expression analysis in HPV16 cervical cancer: identification of altered metabolic pathways

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Genomic mechanisms and measurement of structural and numerical instability in cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

BRCA1 interaction with human papillomavirus oncoproteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

BRCA1 Inhibition of Telomerase Activity in Cultured Cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

BRCA1 regulates p53-dependent gene expression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

BRCA1-associated growth arrest is RB-dependent

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Determinants of genital human papillomavirus detection in a US population

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Multiple biomarkers in molecular oncology. I. Molecular diagnostics applications in cervical cancer detection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Immunohistochemical detection of p16INK4a in liquid-based cytology specimens on cell block sections

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Prognostic markers of high-grade squamous intraepithelial lesions: the role of p16INK4a and high-risk human papillomavirus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Evaluation of p16INK4a expression in ThinPrep cervical specimens with the CINtec p16INK4a assay: correlation with biopsy follow-up results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

MCM immunocytochemistry as a first line cervical screening test in developing countries: a prospective cohort study in a regional cancer centre in India

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Improved cervical smear assessment using antibodies against proteins that regulate DNA replication

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Assessment of gene promoter hypermethylation for detection of cervical neoplasia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

E6AP-dependent degradation of DLG4/PSD95 by high-risk human papillomavirus type 18 E6 protein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

PATJ, a tight junction-associated PDZ protein, is a novel degradation target of high-risk human papillomavirus E6 and the alternatively spliced isoform 18 E6

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Interaction of zyxin, a focal adhesion protein, with the e6 protein from human papillomavirus type 6 results in its nuclear translocation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Multi-PDZ domain protein MUPP1 is a cellular target for both adenovirus E4-ORF1 and high-risk papillomavirus type 18 E6 oncoproteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The E7 oncoprotein of human papillomavirus type 16 interacts with F-actin in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Human papillomavirus-16 E7 interacts with Siva-1 and modulates apoptosis in HaCaT human immortalized keratinocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Human papillomavirus oncoprotein E7 targets the promyelocytic leukemia protein and circumvents cellular senescence via the Rb and p53 tumor suppressor pathways

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

A novel human DnaJ protein, hTid-1, a homolog of the Drosophila tumor suppressor protein Tid56, can interact with the human papillomavirus type 16 E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Human papillomavirus type 16 E7 oncoprotein inhibits apoptosis mediated by nuclear insulin-like growth factor-binding protein-3 by enhancing its ubiquitin/proteasome-dependent degradation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Human papillomavirus 16 E6 oncoprotein interferences with insulin signaling pathway by binding to tuberin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle Arrest

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The DNA repair protein, O(6)-methylguanine-DNA methyltransferase is a proteolytic target for the E6 human papillomavirus oncoprotein.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26 S proteasome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Multiple interference of the human papillomavirus-16 E7 oncoprotein with the functional role of the metastasis suppressor Nm23-H1 protein.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Human papillomavirus type 18 E6 protein binds the cellular PDZ protein TIP-2/GIPC, which is involved in transforming growth factor beta signaling and triggers its degradation by the proteasome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Degradation of tyrosine phosphatase PTPN3 (PTPH1) by association with oncogenic human papillomavirus E6 proteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

PKN binds and phosphorylates human papillomavirus E6 oncoprotein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The human papillomavirus oncoprotein E7 attenuates NF-kappa B activation by targeting the Ikappa B kinase complex

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The human papillomavirus type 11 and 16 E6 proteins modulate the cell-cycle regulator and transcription cofactor TRIP-Br1.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Interaction of human papillomavirus 8 regulatory proteins E2, E6 and E7 with components of the TFIID complex

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Human papillomavirus type 5 E6 oncoprotein represses the transforming growth factor beta signaling pathway by binding to SMAD3

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The human papilloma virus E7 oncoprotein inhibits transforming growth factor-beta signaling by blocking binding of the Smad complex to its target sequence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Rb binds c-Jun and activates transcription

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Identification of the FHL2 transcriptional coactivator as a new functional target of the E7 oncoprotein of human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The HPV-16 E7 oncoprotein binds Skip and suppresses its transcriptional activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Interaction of oncogenic papillomavirus E6 proteins with fibulin-1

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Interaction of human papillomavirus type 11 E7 protein with TAP-1 results in the reduction of ATP-dependent peptide transport

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Human papillomavirus type 16 E7 oncoprotein associates with the centrosomal component gamma-tubulin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

E-cadherin expression is silenced by DNA methylation in cervical cancer cell lines and tumours.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Epigenetic and genetic alternation of PTEN in cervical neoplasm.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Detection of hypermethylated genes in women with and without cervical neoplasia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Frequent hypermethylation of 5' flanking region of TIMP-2 gene in cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Promoter methylation of p16, DAPK, CDH1, and TIMP-3 genes in cervical cancer: correlation with clinicopathologic characteristics.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Methylation of p16INK4a is a non-rare event in cervical intraepithelial neoplasia.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Epstein-Barr virus and p16INK4A methylation in squamous cell carcinoma and precancerous lesions of the cervix uteri

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Hypermethylation of two consecutive tumor suppressor genes, BLU and RASSF1A, located at 3p21.3 in cervical neoplasias

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

IGSF4 promoter methylation and expression silencing in human cervical cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesions.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Methylation profiles of CpG island loci in major types of human cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Methylation status of the fragile histidine triad and E-cadherin genes in plasma of cervical cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Aberrant methylation of HIN-1 (high in normal-1) is a frequent event in many human malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Aberrant methylation of Reprimo in human malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Methylation of p16INK4A in primary gynecologic malignancy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Detection of hypermethylated genes in tumor and plasma of cervical cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Alteration of p16 and p15 genes in human uterine tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Alterations of the P16 gene in uterine cervical carcinoma from Indian patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimens: an approach that utilizes receiver-operating characteristic analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23750

7 January 2021

Identifiers

DOI

10.1002/CNCR.23750

1 reference

19 August 2017

1 reference